Novel Therapies of Breast Cancer

We mean to bolster the distinguishing proof, pharmacological approval, and interpretation of new sub-atomic growth targets. Also, concentrate on early stage approval of novel disease targets, especially through the advancement and utilization of synthetic tests. To encourage the foundation and upkeep of multidisciplinary joint efforts between Imperial College look into groups; predominately at the Chemistry-Medicine.

  • CDK7 inhibition
  • RSK4 inhibition
  • Dual AKT/DNA-PK inhibition
  • Dual EZH2/EHMT2 inhibition

Are you interested in

Mail us at

Breast Congress 2017
breastcongress@alliedconferences.org
Breast Congress 2017
breastcongress@alliedconference.com
More details about sponsorship:sponsors@alliedacademies.com

Authorization Policy


Copyright © 2017-2018 Allied Academies, All Rights Reserved.